Evidence map›Paper›PMID 38882607›Full record

ArticleFrontiers in molecular biosciences2024

Editorial: Proteostasis in cardiac health and disease.

Hannah Bühringer, Shirin Doroudgar, Xuejun Wang, Norbert Frey, Ashraf Yusuf Rangrez

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in molecular biosciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. RNA-Based Therapies for Treating Monogenic Cardiomyopathies.The Canadian journal of cardiology · 2026
    Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hannah BühringerDepartment of Cardiology, Angiology and Pneumology, University Hospital Heidelberg, Heidelberg, Germany.
Shirin DoroudgarDepartment of Internal Medicine and the Translational Cardiovascular Research Center, University of Arizona College of Medicine-Phoenix, Phoenix, AZ, United States.
Xuejun WangDivision of Basic Biomedical Sciences, University of South Dakota Sanford School of Medicine, Vermillion, SD, United States.
Norbert FreyDepartment of Cardiology, Angiology and Pneumology, University Hospital Heidelberg, Heidelberg, Germany.
Ashraf Yusuf RangrezDepartment of Cardiology, Angiology and Pneumology, University Hospital Heidelberg, Heidelberg, Germany.

Funding

Ubiquitin receptors and cardiac proteotoxicityR01HL072166 · NHLBI · UNIVERSITY OF SOUTH DAKOTA · PI WANG, XUEJUN · 2003 to 2023
$6.9M
Cardiac Pathophysiology of Proteasome PhosphoregulationR01HL153614 · NHLBI · UNIVERSITY OF SOUTH DAKOTA · PI XUEJUN WANG · 2020 to 2026
$2.9M
Priming the proteasome to protect against aging and Alzheimer's diseaseRF1AG072510 · NIA · UNIVERSITY OF SOUTH DAKOTA · PI WANG, HONGMIN, WANG, XUEJUN · 2022 to 2022
$1.6M
NHLBI NIH HHS R01 HL072166NHLBI NIH HHS R01 HL153614NIA NIH HHS RF1 AG072510
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cardiac proteostasisdesminopathiesheart failureprotein agglomerationubiquitin proteasomal system

Identifiers

PMID38882607
PMCPMC11176937

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.